SARAH THAYER was named the Merle M. Musselman Centennial Professor of Surgery and chief of surgical oncology at the University of Nebraska Medical Center. She was also named associate director for clinical affairs and physician-in-chief for the Fred & Pamela Buffett Cancer Center at UNMC.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
